Dorlan J Kimbrough

Journal article Lancet Neurol · October 2025 Advances in the understanding of multiple sclerosis and the development of biomarkers of pathophysiology prompted a substantial revision of the 2017 McDonald diagnostic criteria. The new 2024 McDonald criteria provide a unified approach for diagnosing mult ... Full text Link to item Cite

Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria

Journal article LANCET NEUROLOGY · October 2025 Link to item Cite

Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and Australasia.

Journal article Lancet Neurol · October 2024 The differential diagnosis of suspected multiple sclerosis has been developed using data from North America, northern Europe, and Australasia, with a focus on White populations. People from minority ethnic and racial backgrounds in regions where prevalence ... Full text Link to item Cite

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility.

Journal article Science · September 27, 2019 We analyzed genetic data of 47,429 multiple sclerosis (MS) and 68,374 control subjects and established a reference map of the genetic architecture of MS that includes 200 autosomal susceptibility variants outside the major histocompatibility complex (MHC), ... Full text Link to item Cite

Early complement genes are associated with visual system degeneration in multiple sclerosis.

Journal article Brain · September 1, 2019 Multiple sclerosis is a heterogeneous disease with an unpredictable course and a wide range of severity; some individuals rapidly progress to a disabled state whereas others experience only mild symptoms. Though genetic studies have identified variants tha ... Full text Link to item Cite

Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.

Journal article Brain · November 1, 2018 On average, African Americans with multiple sclerosis demonstrate higher inflammatory disease activity, faster disability accumulation, greater visual dysfunction, more pronounced brain tissue damage and higher lesion volume loads compared to Caucasian Ame ... Full text Link to item Cite

Retinal damage and vision loss in African American multiple sclerosis patients.

Journal article Ann Neurol · February 2015 OBJECTIVE: To determine whether African American (AA) multiple sclerosis (MS) patients exhibit more retinal damage and visual impairment compared to Caucasian American (CA) MS patients. METHODS: A total of 687 MS patients (81 AAs) and 110 healthy control ( ... Full text Link to item Cite

Predictors of recurrence following an initial episode of transverse myelitis.

Journal article Neurol Neuroimmunol Neuroinflamm · June 2014 OBJECTIVE: This study sought to identify factors that increased the risk of recurrence after an initial transverse myelitis (TM) presentation. METHODS: Retrospective cohort study of 192 patients initially presenting with TM of unknown etiology. Patients di ... Full text Link to item Cite

Treatment of Neuromyelitis Optica: Review and Recommendations.

Journal article Mult Scler Relat Disord · October 2012 Neuromyelitis optica (NMO) is an autoimmune demyelinating disease preferentially targeting the optic nerves and spinal cord. Once regarded as a variant of multiple sclerosis (MS), NMO is now recognized to be a different disease with unique pathology and im ... Full text Link to item Cite